C - Chemistry – Metallurgy – 12 – P
Patent
C - Chemistry, Metallurgy
12
P
C12P 21/08 (2006.01) A61K 39/395 (2006.01) C07K 16/28 (2006.01) C12N 5/18 (2006.01) G01N 33/574 (2006.01) G01N 33/577 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2107340
-the invention concerns monoclonal antibodies,designated tbp-1, tbp-2 and tbp- 6, against the extracellular part of the hu- man 60 k1) TN tumour necrosis [actor receptor (TNF-BP1). These antibodies are suitable for use in highly semsitive immuno-as says for demonstrating the presence of TNF1-BP 1 in body fluids, including urine, and in cell-culture residues. The determination of the TNF-BP1 concentration as the basis for a diagnosis of pathological conditions associated with activation of the TNF re- ceptor system is thus particularly useful if the ~TNF concentration in the organism falls more rapidly than the TNF-BPI con- centration. In addition, tbp-1 and tbp-6 can he used to strengthen the protective action of TNF-BP1 against (~-TNF and/or (.beta.- TNF-
Boehringer Ingelheim International Gmbh
Boehringer Ingelheim Pharma Gmbh & Co. Kg
Fetherstonhaugh & Co.
LandOfFree
Monoclonal antibodies against human tnf-binding protein i... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Monoclonal antibodies against human tnf-binding protein i..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Monoclonal antibodies against human tnf-binding protein i... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1679277